Contract facts
NONEDEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA BASED ON OUTER MEMBRANE VESICLES COMBINED WITH SUSTAINED-RELEASE MICROSPHERES CONTAINING RECOMBINANT HUMAN INTERLEUKIN-12. is a federal NONE award for National Institutes Of Health Niaid held by Intravacc B.V. Estimated value $14.6M ($6.6M obligated). Current period of performance ends Dec 30, 2026. Last award drew 10 bidders. Related solicitation 2021-1.
DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA BASED ON OUTER MEMBRANE VESICLES COMBINED WITH SUSTAINED-RELEASE MICROSPHERES CONTAINING RECOMBINANT HUMAN INTERLEUKIN-12.
Recompete timing
PublicCurrent PoP ends Dec 30, 2026 (114 days remaining). Agencies typically plan 12–18 months ahead — at 3.7 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordIntravacc B.V — $6.5M obligated across 2 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93022C00058?
75N93022C00058 (Development of an intranasal vaccine against) is a National Institutes Of Health Niaid award with a potential value of $14.6M, currently held by Intravacc B.V. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93022C00058?
National Institutes Of Health Niaid awarded 75N93022C00058 to Intravacc B.V (potential $14.6M).
Who is the incumbent on 75N93022C00058?
Intravacc B.V is the incumbent with $6.5M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 30, 2026.
When does Intravacc B.V’s 75N93022C00058 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93022C00058 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.